HealthEquity, Inc. $HQY Stock Purchased by GW&K Investment Management LLC

GW&K Investment Management LLC lifted its position in shares of HealthEquity, Inc. (NASDAQ:HQY – Free Report) by 56.5% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 989,427 shares of the company’s stock after buying an additional 357,045 shares during the period. HealthEquity makes up approximately 0.7% of GW&K Investment Management LLC’s portfolio, making the stock its 27th largest position. GW&K Investment Management LLC owned about 1.20% of HealthEquity worth $87,525,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also made changes to their positions in the company. BlackRock Inc. acquired a new stake in shares of HealthEquity during the 2nd quarter worth about $1,018,621,000. William Blair Investment Management LLC purchased a new stake in shares of HealthEquity in the 2nd quarter worth about $160,158,000. Bank of America Corp DE purchased a new position in HealthEquity during the second quarter worth $103,573,000. Atalan Capital Partners LP purchased a new position in shares of HealthEquity during the 2nd quarter worth $82,667,000. Finally, Jupiter Topco LLC acquired a new position in shares of HealthEquity in the 2nd quarter valued at $78,847,000. Hedge funds and other institutional investors own 99.55% of the company’s stock.

Insider Buying and Selling at HealthEquity

In other HealthEquity news, Director Adrian Dillon sold 7,632 shares of the stock in a transaction dated Tuesday, August 25th. The stock was sold at an average price of $104.61, for a total transaction of $798,383.52. Following the completion of the sale, the director directly owned 62,395 shares in the company, valued at approximately $6,527,140.95. This trade represents a 10.90% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 1.60% of the company’s stock.

Wall Street Analyst Weigh In

HQY has been the subject of several analyst reports. Citigroup reaffirmed a “market outperform” rating on shares of HealthEquity in a research report on Friday, August 28th. Wall Street Zen upgraded shares of HealthEquity from a “hold” rating to a “buy” rating in a research report on Saturday, October 10th. Weiss Ratings downgraded HealthEquity from a “buy (b)” rating to a “buy (b-)” rating in a research note on Tuesday. BMO Capital Markets raised their target price on HealthEquity from $105.00 to $125.00 and gave the company an “outperform” rating in a report on Wednesday, October 21st. Finally, Deutsche Bank upped their price target on HealthEquity from $135.00 to $142.00 and gave the stock a “buy” rating in a report on Monday, August 31st. One investment analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $113.53.

Read Our Latest Research Report on HQY

HealthEquity Stock Performance

HQY opened at $97.38 on Friday. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.99 and a quick ratio of 2.99. HealthEquity, Inc. has a 1 year low of $72.76 and a 1 year high of $110.26. The business’s 50-day moving average price is $96.57 and its two-hundred day moving average price is $90.28. The company has a market capitalization of $8.05 billion, a price-to-earnings ratio of 35.16, a P/E/G ratio of 1.54 and a beta of 0.22.

HealthEquity (NASDAQ:HQY – Get Free Report) last released its quarterly earnings data on Thursday, August 27th. The company reported $1.24 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.19 by $0.05. HealthEquity had a return on equity of 15.33% and a net margin of 17.36%. The firm had revenue of $350.73 million for the quarter, compared to analyst estimates of $349.22 million. The business’s quarterly revenue was up 95.5% compared to the same quarter last year. HealthEquity has set its FY 2027 guidance at 4.660-4.730 EPS. Equities analysts expect that HealthEquity, Inc. will post 3.94 EPS for the current fiscal year.

About HealthEquity

(Free Report)

HealthEquity, Inc. provides technology and services for health savings accounts (HSAs) and other consumer-directed benefits. Its platform supports employers, health plans, benefits advisers and individuals in managing health-related accounts and benefits. Alongside HSAs, the company administers flexible spending accounts, health reimbursement arrangements, commuter benefits and other workplace benefit programs. Its services include account administration, payment tools, customer support and investment options for eligible HSA funds.

Further Reading

Institutional Ownership by Quarter for HealthEquity (NASDAQ:HQY)

Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.